Cardiac Biomarkers Testing Market Forecast and Analysis: Key Insights into Growth, Trends, and Emerging Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Will the Growth Rate of the Cardiac Biomarkers Testing Market Shape Industry Trends by 2034?
The market for cardiac biomarkers testing has seen a swift expansion in the past few years. The market is projected to expand from $13.48 billion in 2024 to reach a total value of $15.09 billion in 2025, with a compound annual growth rate (CAGR) of 12.0%. Various factors have contributed to this growth in the past, including an increase in cardiovascular disease prevalence, an aging population, ongoing education and awareness efforts, government policies concerning healthcare, and a rise in overall health care spending.
Rapid expansion is anticipated in the cardiac biomarkers testing market size in the forthcoming years. It is projected to reach $23.75 billion by 2029, with a compound annual growth rate (CAGR) of 12.0%. The expected growth during the forecast period could be due to factors like personalized medicine, the escalating global incidence of cardiovascular diseases, application of artificial intelligence (AI) in diagnostics, growth of point-of-care testing, and a heightened focus on early disease detection. Key trends during this forecasted period could be technological enhancements, advancements in AI-supported diagnostics, expansion of point-of-care testing (POCT), greater multiplexing capacities, and progress in biomarker identification and confirmation.
How Are the key drivers Contributing to the Expansion of the cardiac biomarkers testing Market?
The escalating cases of heart-related diseases are projected to propel the expansion of the cardiac biomarkers testing market. Such ailments typically impact the heart or the blood vessels. The test for cardiac biomarker aids in identifying the concentration of biomarkers, enabling an immediate assessment of a heart attack’s severity and extent. Consequently, a surge in the occurrence of heart diseases is anticipated to heighten the need for cardiac biomarker testing solutions. For example, the American College of Cardiology, a professional medical organization based in the US, predicted in August 2022 that cardiovascular risk factors and diseases would notably increase in the US by 2060. Thus, the rising incidence of heart diseases is fuelling the growth of the cardiac biomarkers testing market.
Get Your Free Sample of the Global Cardiac Biomarkers Testing Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9436&type=smp
Who Are the Key Market Players Influencing the Growth of the Cardiac Biomarkers Testing Industry?
Major companies operating in the cardiac biomarkers testing market include:
• Abbott Laboratories_x000D_
• Bio-Rad Laboratories Inc._x000D_
• Danaher Corporation_x000D_
• F. Hoffmann-La Roche Ltd._x000D_
• Siemens Healthineers AG_x000D_
What Key Market Trends Are Shaping the Future of the Cardiac Biomarkers Testing Industry?
In the cardiac biomarker testing market, top-tier corporations are focusing on establishing strategic collaborations to deliver technology capable of signaling preliminary symptoms of heart diseases, aiming to enhance patient recovery rates. Such strategic alliances within the cardiac biomarker testing sector promote interactive cooperation which paves the way for ground-breaking diagnostics, extends market footprint, and expedites the availability of high-end testing answers for superior cardiovascular treatment. For instance, in September 2024, an Indian healthcare technology firm named MediBuddy, offering a holistic platform for virtual health services, health management, and insurance aid, formed a partnership with Philips, a conglomerate corporation hailing from the Netherlands. The goal of this alliance is to reinforce cardiac care in India by assimilating Philips’ HeartPrint technology, facilitating continuous observation and hazard assessment of cardiac health. This progressive strategy endows MediBuddy platform’s users with sophisticated implements, advocating active supervision of cardiac health and enhanced outcomes.
Get Instant Access to the Global Cardiac Biomarkers Testing Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report
What Major Market Segments Define the Scope and Growth of the Cardiac Biomarkers Testing Market?
The cardiac biomarkers testing market covered in this report is segmented –
1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types
2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications
3) By End-User: Hospitals, Specialty Clinics
Subsegments:
1) By Creatine Kinase (CK-MB): Total CK-MB, CK-MB Mass
2) By Troponins: Cardiac Troponin I (cTnI), Cardiac Troponin T (cTnT)
3) By Myoglobin: Total Myoglobin
4) By Natriuretic Peptides: B-Type Natriuretic Peptide (BNP), N-Terminal Pro B-Type Natriuretic Peptide (NT-ProBNP)
5) By Ischemia Modified Albumin (IMA): IMA Levels
6) By Other Biomarkers Types: C-Reactive Protein (CRP), Heart-Type Fatty Acid-Binding Protein (H-FABP), Soluble ST2
Which Regions Are Emerging as Leaders in the Cardiac Biomarkers Testing Market?
North America was the largest region in the cardiac biomarkers testing market in 2024. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Defining Features of the Cardiac Biomarkers Testing Market?
Cardiac biomarkers testing refers to the tests to evaluate the quantities of cardiac biomarkers in blood. It is used to diagnose, assess, and keep track of people who may have acute coronary syndrome (ACS).
Browse Through More Similar Reports By The Business Research Company:
Interventional Cardiology Devices And Equipment Global Market Report 2024
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024
Cardiovascular Medical Lasers Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiovascular-medical-lasers-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
